EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro.

from US Top News and Analysis https://ift.tt/vmRtT0A
https://ift.tt/v8xmy3e